Discuss a Payer Review Timeline With Useful Precision

A clinic coordinator calls asking when a payer will finish reviewing a new therapy for coverage. Your instinct as a market access manager is to sound helpful and give a number, even a rough one. That instinct causes problems. Payers move on their own schedule, committees postpone, and a guessed date becomes a promise the moment you say it out loud. This post covers how to talk about a payer review timeline with real precision, so you sound informed without predicting an outcome you do not control.

Why this conversation goes wrong

Stakeholders ask about timing because real people are waiting on it. A clinic wants to know when it can start prescribing without a coverage fight. A patient wants to know when a claim will stop getting denied. That pressure pushes you toward giving an answer that feels complete, even when the honest answer is that the committee has not met yet.

The failure mode is subtle. You are not lying. You are rounding up. Someone asks when a decision is expected, and you say something like early next quarter, because that is when the committee usually meets. The listener hears a commitment. Three months later, when the date slips, you are the person who was wrong, even though you never had the authority to be right in the first place.

The second failure mode is the opposite problem, going so vague that you sound useless. If you refuse to say anything concrete, the stakeholder assumes you are hiding bad news or that you do not know your own account. Precision means stating exactly what is known, exactly what is not known, and where the gap gets closed.

How to prepare

Before you get on a call about timing, pull the actual record instead of relying on memory. Check what the payer has published or communicated in writing about its review process, including whether a formal committee meeting date exists. A scheduled meeting is a fact. A decision date is not, until the payer issues one.

Confirm who owns the verified update on your side. If a colleague on the payer relations team gets the notice before you do, know that and say so, instead of promising to personally track it down. Also figure out what the stakeholder actually needs. Sometimes the real question is not when will this be decided but what can we do in the meantime, such as accessing current approved materials, understanding a prior authorization pathway, or preparing evidence the payer might request next. If you have handled a related situation, such as a plan asking for utilization data, the approach in Respond to a Utilization Baseline Request applies here too, because both conversations depend on separating what you can confirm from what you are being asked to forecast.

Write down the three things you will say before the call. State the stage the review is currently in. State the next checkpoint where information becomes verifiable. State who to contact if the stakeholder needs a status check between now and then. That structure keeps you from drifting into a guess when someone pushes for more.

What to say

Here is a realistic exchange. A coordinator at a health system opens with the question everyone asks.

The coordinator says, "Can you give us a sense of when the plan will make a decision on this."

You say, "I can tell you the stage the review is in and who can confirm updates as they happen. From what the plan has shared with your team, has a committee meeting date been set."

The coordinator says, "There is a meeting on the calendar, but nobody has told us when the actual decision comes out."

You say, "That matches what we have too, a scheduled meeting but no published decision date. I will not guess at a date beyond that, because the plan controls when it issues one. What I can do is send over the current approved materials so your team has something solid to work from while we wait, and flag you the moment a verified update comes through."

Notice what happened in that exchange. You did not repeat the question back and stall. You gave a real answer, the stage of review and the meeting status, and you separated that from the thing you refused to invent, a decision date. You also offered something useful right now, the approved materials, so the coordinator leaves with more than a shrug.

If the coordinator pushes again and asks for your best guess anyway, hold the line without getting defensive. You say, "I understand the team wants to plan around a date. If I gave you one now it would be a guess dressed up as information, and that would do your team more harm than good if it turned out to be wrong. I would rather get you a confirmed date the moment the plan issues one."

Mistakes to avoid

A few habits sink this conversation more than any single wrong word.

1. Turning a meeting date into a decision date. A scheduled committee session is not the same as a resolution, and treating it that way sets a false expectation.

2. Softening a guess with words like probably or likely so it sounds hedged, when the listener still walks away with a specific number in their head.

3. Going silent instead of offering an alternative. If you cannot give a date, give the stakeholder something else, current materials, a policy explanation, or a status contact.

4. Promising to personally chase down information you do not own. Name the actual verification path instead of implying you will handle everything yourself.

5. Letting frustration from repeated questions make you short with the stakeholder. Clinics and members are waiting on real care decisions. Their persistence is reasonable even when it is uncomfortable for you.

How to practice and score it

This conversation is hard to get right the first time you face it live, because the pressure to fill silence with a number is strong. Practice it with a colleague who plays the stakeholder and pushes for certainty at least three times in a row, each time a little more insistent. Notice whether you hold the line on the same facts each time or whether your answer drifts toward a firmer date under pressure.

Score yourself, or have a manager score you, on three things. Did you name the actual review stage without inflating it. Did you avoid stating or implying a decision date that has not been published. Did you offer something concrete, materials, a contact, or a next checkpoint, instead of leaving the stakeholder with nothing. DealSpeak's pharmaceuticals scenarios are built around exactly this kind of pressure test, where the AI counterpart keeps asking for certainty and scores how well you separate fact from forecast. If you want to see how this same discipline applies to a related conversation, Set Scientific Boundaries in an Advisory Discussion covers the same instinct to stay precise when someone wants you to say more than you actually know.

You can browse more scenarios like this one on the Pharmaceuticals practice conversations page, built around the calls market access managers actually get.

Close

A payer review timeline is not yours to predict, only yours to describe accurately. Say what stage the review is in, name the next real checkpoint, and give the stakeholder something useful to act on while they wait. That is a better answer than a guessed date, and it holds up when the schedule inevitably shifts.

You can rehearse this exact conversation in the Pharmaceuticals practice conversations library before it happens for real. When you have this one down, read Respond to a Utilization Baseline Request next.